Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125645532 | 12564553 | 2 | F | 20160617 | 20160818 | 20160718 | 20160824 | EXP | GB-DRREDDYS-GER/UKI/16/0081243 | DR REDDYS | 62.00 | YR | M | Y | 0.00000 | 20160824 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125645532 | 12564553 | 1 | PS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | U | U | UNKNOWN | 91365 | 2000 | MG | |||||||
| 125645532 | 12564553 | 2 | SS | CARBOPLATIN. | CARBOPLATIN | 1 | U | U | 0 | 290 | MG | ||||||||
| 125645532 | 12564553 | 3 | SS | NEULASTA | PEGFILGRASTIM | 1 | Subcutaneous | U | U | 0 | 6 | MG | |||||||
| 125645532 | 12564553 | 4 | C | CEFALEXIN | CEPHALEXIN | 1 | 0 | ||||||||||||
| 125645532 | 12564553 | 5 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | 0 | ||||||||||||
| 125645532 | 12564553 | 6 | C | Domperidone | DOMPERIDONE | 1 | 0 | ||||||||||||
| 125645532 | 12564553 | 7 | C | Ondansetron | ONDANSETRON | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125645532 | 12564553 | 1 | Product used for unknown indication |
| 125645532 | 12564553 | 2 | Product used for unknown indication |
| 125645532 | 12564553 | 3 | Product used for unknown indication |
| 125645532 | 12564553 | 4 | Product used for unknown indication |
| 125645532 | 12564553 | 5 | Product used for unknown indication |
| 125645532 | 12564553 | 6 | Product used for unknown indication |
| 125645532 | 12564553 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125645532 | 12564553 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125645532 | 12564553 | Abdominal pain lower | |
| 125645532 | 12564553 | Back pain | |
| 125645532 | 12564553 | Body temperature increased | |
| 125645532 | 12564553 | Constipation | |
| 125645532 | 12564553 | Device infusion issue | |
| 125645532 | 12564553 | Energy increased | |
| 125645532 | 12564553 | Erythema | |
| 125645532 | 12564553 | Eye disorder | |
| 125645532 | 12564553 | Fatigue | |
| 125645532 | 12564553 | Gout | |
| 125645532 | 12564553 | Haemoglobin decreased | |
| 125645532 | 12564553 | Infusion site haemorrhage | |
| 125645532 | 12564553 | Infusion site pain | |
| 125645532 | 12564553 | Infusion site reaction | |
| 125645532 | 12564553 | Mouth ulceration | |
| 125645532 | 12564553 | Myalgia | |
| 125645532 | 12564553 | Neutrophil count decreased | |
| 125645532 | 12564553 | Ocular hyperaemia | |
| 125645532 | 12564553 | Oral pain | |
| 125645532 | 12564553 | Underdose | |
| 125645532 | 12564553 | Urinary tract infection | |
| 125645532 | 12564553 | Vasospasm | |
| 125645532 | 12564553 | Visual impairment | |
| 125645532 | 12564553 | White blood cell count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |